Arenicin-1 vs Exendin-4
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Exendin-4 (Exendin-4 (synthetic exenatide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Exendin-4 |
|---|---|---|
| Category | Marine-Derived | Diabetes & Metabolic |
| Full Name | Arenicin-1 | Exendin-4 (synthetic exenatide) |
| Molecular Weight | 2079 Da | 4186 Da |
| Half-Life | n/a | 2.4 hours |
| Amino Acids | 21 | 39 |
| Typical Dose | n/a | 5-10 mcg twice daily |
| Route | preclinical | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 1800 |
| Research Status | Pre-clinical | Clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Exendin-4 Benefits
- ✓beta-cell survival
- ✓glucose-stimulated insulin secretion
- ✓reduced glucolipotoxicity
- ✓lowered HbA1c in clinical use
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Exendin-4 Dosing
5 mcg SC twice daily for 4 weeks|increase to 10 mcg SC twice daily if tolerated|research: 0.1-1 µM in vitro or 1-10 µg/kg in animals
Arenicin-1 Side Effects
- ⚠Arenicola marina
Exendin-4 Side Effects
- ⚠nausea
- ⚠vomiting
- ⚠injection-site reactions
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Exendin-4
Exendin-4 helped establish GLP-1 receptor biology in diabetes and remains a classic beta-cell protective peptide. Preclinical studies show reduced beta-cell apoptosis, improved insulin content, and better islet function under metabolic stress.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.